90124-16-6 Usage
Explanation
This is the IUPAC name of the compound, which provides information about the structure and stereochemistry of the molecule.
Explanation
These are alternative names for the compound, which can be used interchangeably.
Explanation
Phenol ethers are a class of organic compounds that consist of an aryl group (such as phenyl) bonded to an ether group. 1-Butanol, 3-(phenylmethoxy)-, (S)- belongs to this class.
Explanation
The compound is primarily used in the pharmaceutical industry as a building block for the synthesis of other compounds and drugs. It also has potential applications in organic chemistry as a reagent for the synthesis of complex organic molecules.
Explanation
The stereochemistry of the compound is important, as it plays a crucial role in its pharmacological properties. The (S)designation indicates the specific arrangement of atoms in the molecule, which can affect its biological activity.
Explanation
The compound has a range of industrial applications, including its use in the synthesis of pharmaceutical and organic compounds.
Synonyms
S-1-phenyl-3-butoxy-1-propanol
Class
Phenol ethers
Applications
Pharmaceutical industry, organic chemistry
Stereochemistry
(S)-
Chiral Intermediate
Important in the production of pharmaceuticals
Industrial Uses
Diverse
Check Digit Verification of cas no
The CAS Registry Mumber 90124-16-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,1,2 and 4 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 90124-16:
(7*9)+(6*0)+(5*1)+(4*2)+(3*4)+(2*1)+(1*6)=96
96 % 10 = 6
So 90124-16-6 is a valid CAS Registry Number.
90124-16-6Relevant academic research and scientific papers
First Synthesis and Characterization of Stereoisomers of Choleretic Drug Dihydroxydibutylether
Yue, Qiming,Zhao, Yi,Sun, Baohou,Hai, Li,Guo, Li,Wu, Yong
, p. 1145 - 1152 (2015/11/02)
Dihydroxydibutylether (DHBE) is a choleretic drug used for the treatment of gallstone and hepatic disorders due to its choleretic activity and hepatoprotective action. The drug is a mixture of three regioisomers. The main regioisomer 3-(3-hydroxylbutoxy)-
Total synthesis of the proposed structure of the anthrapyran metabolite δ-indomycinone
Tietze, Lutz F.,Singidi, Ramakrishna Reddy,Gericke, Kersten M.
, p. 9939 - 9947 (2008/09/18)
The first total synthesis of the proposed structure of δ-indomycinone has been accomplished. The key steps involve the Diels-Alder reaction of a bromonaphthoquinone (6) and 1-methoxy-3-methyl-1-trimethylsiloxy-1,3-butadiene (7) to access the anthraquinone
Synthesis of N-butyl side chain hydroxylated metabolites of roxifiban, a platelet glycoprotein IIB/IIIA receptor antagonist
Sun, Jung-Hui,Emmett, George C.,Hytrek, Janice L.,Yan, Jia-Sheng,Tabaka-Blom, A. Christine,Teleha, Christopher A.
, p. 1585 - 1599 (2007/10/03)
Syntheses of three n-butyl side chain hydroxylated metabolites of Roxifiban (5, 6a and 6b) are reported. Initial use of benzyl as hydroxyl protecting group gave poor yield during its removal by catalytic hydrogenation, due to complication from N-O cleavage of the isoxazoline. This problem was eliminated by the use of TBDMS as the hydroxyl protecting group. The chemical structures of these metabolites as well as the intermediates have been fully characterized.
